ATHENS, Greece, June 30, 2017 /Weed Wire/ — Published today in the Official Gazette, Joint Ministerial Decision (JMD) Ministers of Health and Justice, which opens the way for the introduction of approved medications and hemp products. These formulations are indicated for cases that have proven clinical benefit for a variety of diseases such as chronic pain, neuropathic pain, nausea and vomiting due to chemotherapy, cachexia / anorexia. etc.
This CMD implements the findings of the Scientific Committee set up on the initiative of Health Minister Andreas Xanthos, in order to assess the contemporary experience and existing legislation regarding the medical use of cannabis and the submission of proposals for a regulatory framework that will regulate the issue.
The measure requires a number of additional administrative procedures which will go directly to patients to gain access to medicines as soon as possible.